149P HER2-low status and response to neoadjuvant chemotherapy in early breast cancer

Autor: Alkan, G., Oztas, N. Senturk, Degerli, E., Safarov, S., Guliyev, M., Gunaltili, M., Can, G., Demirci, N.S., Turna, Z.H., Demirelli, F.H., Ozguroglu, M.
Zdroj: In ESMO Open May 2023 8(1) Supplement 4
Databáze: ScienceDirect